Human exposure to dithiocarbamates derives from their many uses in agriculture, industry. and medicine. Although the degradative and metabolic pathways of dithiocarbamates are fairly well understood, there is currently little knowledge regarding the molecular targets and mechanisms underlying the observed biological effects of dithiocarbamates. The long range objectives of this project are to delineate the interactions of dithiocarbamates and their metabolites within biological systems, and to determine both the relevance of these interactions as mechanisms of toxicity and the utility of these interactions as biomarkers of exposure and effect. Previous investigations have demonstrated the ability of N,N-diethyldithiocarbamate to produce a CS2-mediated central-peripheral distal axonopathy whereas its disulfide, disulfiram, produces a selective Schwann cell neurotoxicity. The investigations in this application are guided by the following working hypotheses: 1)bis(thiocarbamoyl) disulfides exert Schwann cell toxicity from bioactivation to a thiocarbamate sulfoxide metabolite capable of inhibiting myelin synthesis via covalent modification of cysteine residues; 2)disulfiram inhibits low Km aldehyde dehydrogenase by carbamylation of an active site cysteine residue; 3)thiocarbamate esters as well as other compounds that can be metabolized to thiocarbamate sulfoxides are neurotoxic through a mechanism identical to bis(thiocarbamoyl) disulfides. These hypotheses will be tested through determining the relative neurotoxic potencies of bis(thiocarbamoyl)disulfide and thiocarbamate esters in vitro and in vivo using altered expressions of Po and p75; determining the identity and location of proteins covalently modified by dithiocarbamates within the nervous system and liver; determining the influence of age, route of exposure and acid stability on dithiocarbamate induced neurotoxicity; and determining the effects of disulfiram upon myelin synthesis within Schwann cells. Delineating the mechanisms of toxicity, defining the biological effects, and identifying susceptible populations for dithiocarbamates will aid in developing mechanistically based exposure recommendations and formulating structure activity relationships for predicting other agents that may act through a similar mechanism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES006387-10
Application #
6635456
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Lawler, Cindy P
Project Start
1994-01-01
Project End
2005-02-28
Budget Start
2003-03-10
Budget End
2004-02-29
Support Year
10
Fiscal Year
2003
Total Cost
$264,250
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Valentine, Holly L; Viquez, Olga M; Valentine, William M (2010) Peripheral nerve and brain differ in their capacity to resolve N,N-diethyldithiocarbamate-mediated elevations in copper and oxidative injury. Toxicology 274:10-7
Viquez, Olga M; Lai, Barry; Ahn, Jae Hee et al. (2009) N,N-diethyldithiocarbamate promotes oxidative stress prior to myelin structural changes and increases myelin copper content. Toxicol Appl Pharmacol 239:71-9
Valentine, Holly L; Viquez, Olga M; Amarnath, Kalyani et al. (2009) Nitrogen substituent polarity influences dithiocarbamate-mediated lipid oxidation, nerve copper accumulation, and myelin injury. Chem Res Toxicol 22:218-26
Valentine, William M; Abel, Ty W; Hill, Kristina E et al. (2008) Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J Neuropathol Exp Neurol 67:68-77
Viquez, Olga M; Valentine, Holly L; Amarnath, Kalyani et al. (2008) Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy. Toxicol Appl Pharmacol 229:77-85
Viquez, Olga M; Valentine, Holly L; Friedman, David B et al. (2007) Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy. Chem Res Toxicol 20:370-9
Valentine, Holly L; Does, Mark D; Marshall, Vivian et al. (2007) Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination. Neurotoxicology 28:645-54
Valentine, Holly; Amarnath, Kalyani; Amarnath, Venkataraman et al. (2007) Globin s-propyl cysteine and urinary N-acetyl-S-propylcysteine as internal biomarkers of 1-bromopropane exposure. Toxicol Sci 98:427-35
Valentine, Holly L; Amarnath, Kalyani; Amarnath, Venkataraman et al. (2006) Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate. Toxicol Sci 89:485-94
Valentine, William M; Hill, Kristina E; Austin, Lori M et al. (2005) Brainstem axonal degeneration in mice with deletion of selenoprotein p. Toxicol Pathol 33:570-6

Showing the most recent 10 out of 32 publications